Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Randomized, Double-blind, Placebo-controlled Study in HLA-DQ2.5+ Adults With Celiac Disease to Assess the Effect of Nexvax2 on Symptoms After Masked Gluten Food Challenge

NCT03644069 is registered in ClinicalTrials.gov with ImmusanT, Inc. as lead sponsor.

NCT NCT03644069
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03644069 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Randomized, Double-blind, Placebo-controlled Study in HLA-DQ2.5+ Adults With Celiac Disease to Assess the Effect of Nexvax2 on Symptoms After Masked Gluten Food Challenge
Lead sponsor
ImmusanT, Inc.
Phase
Phase 2
Overall status
Unknown status
Start date
August 6, 2018
Completion date
September 30, 2019
Enrollment
146 (estimated)
Sites
41

Conditions

As the registry lists them; a condition with its own page is linked.

autoimmune diseases, celiac, celiac disease, digestive system disease, gastrointestinal disease, gluten sensitivity, intestinal disease, malabsorption syndromes